Name: Follicle Stimulating Hormone Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: PH4562
Price: 4350 USD
Availability: InStock

Follicle Stimulating Hormone Market Size Share Growth and Forecast 2023

Follicle Stimulating Hormone Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Follicle Stimulating Hormone Market&nbsp;is segmented&nbsp;By Type (Recombinant FSH,&nbsp;Urinary FSH),&nbsp;By Application(Infertility Treatment,&nbsp;Assisted reproductive technology (ART),&nbsp;Others),&nbsp;By End-User(Infertility Center,&nbsp;Hospitals,&nbsp;Others),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, &nbsp;2023 - 2030</h2>

&nbsp;

<h2>Follicle Stimulating Hormone Market Overview</h2>

<blockquote>
The Global Follicle Stimulating Hormone Market reached US$ 1.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 2.9 billion by 2030. The global follicle stimulating hormone market is expected to exhibit a CAGR of 5.8% during the forecast period (2023-2030).&nbsp;The global follicle stimulating hormone market has grown significantly in recent years and is projected to continue on its upward trend.
</blockquote>

The market is currently going through a period of significant change that is being fueled by a number of trends, such as the growing demand for personalized FSH treatments, the switch from urinary-derived to recombinant FSH, improvements in drug delivery systems, and a growing focus on treating male infertility.

Furthermore, the increasing prevalence of infertility, advancements in assisted reproductive technologies (ART), growing awareness and acceptance of fertility treatments, and growing aging population are driving the follicle stimulating hormone market size. Due to the advancements of technologies in these fields, the market is seeing an increase in demand from North American&nbsp;regions. Significant competitors like GenPharm, Midas Pharma GmbH, Merck Sharp &amp; Dohme Corp, and others are actively operating in the market.

<h2>&nbsp;</h2>

<h2>Follicle Stimulating Hormone Market Scope</h2>

<table cellspacing="0" style="border-collapse:collapse; width:624px">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			5.8%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Type, Application, End User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Infection Type Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

To know More Insights -&nbsp;<a href="https://www.datamintelligence.com/download-sample/follicle-stimulating-hormone-market">Download Sample</a>

&nbsp;

<h2>Follicle Stimulating Hormone Market Dynamics</h2>

<h3>The Increasing Prevalence of Infertility to Drive the Growth of the Follicle Stimulating Hormone Market</h3>

The increased prevalence of infertility globally is an important driver for the follicle stimulating hormon (FSH) market. Changing lifestyles, delayed parenthood, hormone diseases, and environmental factors contribute to the rising prevalence of infertility. FSH is an essential part of fertility treatments because it stimulates follicular growth in women and sperm production in men.&nbsp;

For instance, the Center for Disease Control and Prevention (CDC) reported in 2023 that infertility has significant effects on people, their families, and larger communities. Infertility is anticipated to impact one in six people around the world who are of reproductive age at some point in their lives.&nbsp;

Infertility in males is frequently related to problems with semen ejaculation, low sperm counts or sperm absence, abnormalities in sperm morphology and mobility, as well as other factors. Infertility in women can result from a variety of problems that impact the uterus, fallopian tubes, ovaries, and endocrine system, among other things. Therefore, the above-mentioned factors are expected to drive the global follicle stimulating hormone market growth over the forecast period.

<h3>Technological Innovations in FSH Products Will Drive the Growth of Follicle Stimulating Hormone Market</h3>

The development of technologically advanced FSH products is another driving factor in the market. The manufacturers are spending&nbsp;on R&amp;D to increase the efficacy, safety, and usability of FSH formulations. This includes the creation of recombinant FSH products, which have advantages to urinary-derived FSH such as higher purity, consistent potency, and a lower chance of contamination.

For instance, Bharat Serums and Vaccines Limited is conducting a clinical trial using Recombinant Human Follicle Stimulating Hormone for treating infertility. About 250 women in the age group of 20 to 39 years have participated in this trial and currently, it is in phase 3 trial and the estimated completion of the trial is in November 2023. Thus, increasing innovations will drive the growth of the global follicle stimulating hormone market.

<h3>The High FSH Treatment Cost will Hamper the Growth of the Market.&nbsp;</h3>

FSH treatments can be expensive, especially when paired with other forms of assisted reproduction. The exorbitant expenses of drugs, diagnostic tests, and procedures may make FSH therapies inaccessible, particularly in underdeveloped countries. For instance, a single IVF cycle with FSH stimulation can cost thousands of dollars, leaving it out of reach for a large section of the population in developing and underdeveloped countries.

&nbsp;

<h2>Follicle Stimulating Hormone Market Segment Analysis</h2>

The global follicle stimulating hormone market is segmented based on type, application, end user, and region.

<h3>Owing to the Effectiveness, the&nbsp; Assisted Reproductive Technology (ART) Segment Accounted for Approximately 54.6% of the Follicle Stimulating Hormone Market Share</h3>

ART treatments, such as in vitro fertilization (IVF), intrauterine insemination (IUI), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and frozen embryo transfer (FET) have grown in popularity and success in assisting couples in achieving conception. Rising infertility rates, advancements in ART techniques, and increased acceptance and awareness are some of the drivers that will drive industry expansion.&nbsp;

Moreover, FSH is important in ART because it stimulates follicular development, which increases the odds of successful fertilization. During the procedure, the woman&#39;s egg is extracted from her body and mixed with sperm to create embryos, which are subsequently returned to her body. For successful fertilization, ART treatments can also involve donor eggs, donor sperm, or even donated embryos.

Furthermore, controlled ovarian hyperstimulation (COH) is used in ART treatments such as IVF and embryo transfer. Human follicle-stimulating hormones (hFSHs) play an important role in COH by increasing the development and maturation of numerous follicles in order to generate high-quality oocytes and improve clinical pregnancy success rates. As a result of the importance of FSH in COH for ART treatments, the ART sector is expected to have the biggest market share over the projection period.

<img src="https://lh5.googleusercontent.com/2zQYXJ8XfBIxDUzagOaBxW1rFusJJUyWrweUrWZumjCD55_0ir7vvqIhe_EL5Uq1weD47f5iziGfp3JtlOGSQjzmZRFhvNJ-g8MkM8_kHGn4J1j4Ne10c5yIw7K2Rlm_EB0TvDm4jbw9LEFXwlXkuw" style="height:336px; width:576px" />

Source: DataM Intelligence Analysis (2023)

<h2>&nbsp;</h2>

<h2>Follicle Stimulating Hormone Market Geographical Penetration</h2>

<h3>North America Accounted for Approximately 41.4% of the Market Share in 2022, Owing to Technological Advancements and Better Government Initiatives</h3>

Infertility rates are increasing in North America as a result of a considerable rise in the number of people reaching older ages. The need for fertility treatments, including FSH-based therapies, is anticipated to rise as people put off having children or struggle with age-related infertility. Moreover, North America has a well-developed healthcare infrastructure, advanced reproductive technologies, and a favorable reimbursement landscape.

For instance, according to World Health Organization (WHO) 2022 report, by 2030, about one out of every six people on the planet will be 60 or older. Within this time span, the share of the world population aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion. In 2050, the number of persons aged 60 and up will more than treble, approaching 2.1 billion. Hence, the market is expected to witness growth over the forecast period due to the above-mentioned factors.

<img src="https://lh5.googleusercontent.com/o0uQ6QPmIVL2R6F3BGJGPxWuCvbao91JuWa1cmRxB9H6h0gVhsP-VzMDtPR6F09wroHIw7TaJLPPY_JZCIxSX-p2wm09Ly77WyRVo59CghmGLEaSd-An-NzPvd8-ZVrTyZexkAWLaATOL7VkllLRTg" style="height:336px; width:576px" />

Source: DataM Intelligence Analysis (2023)

<h2>&nbsp;</h2>

<h2>Follicle Stimulating Hormone Market Players</h2>

The major global players in the follicle stimulating hormone market include Merck Serono, Creative BioMart, Midas Pharma GmbH, GenPharm, Trumac Healthcare, Livzon, Shanghai Techwell Biopharmaceutical Co., Ltd., Merck Sharp &amp; Dohme Corp, Lee Biosolutions,Inc, and BIOGENIX INC.PVT.LTD.&nbsp;

&nbsp;

<h2>COVID-19 Impact on&nbsp;Follicle Stimulating Hormone Market</h2>

Russia-Ukraine Conflict Analysis

The conflict between Russia and Ukraine has the potential to cause supply chain interruptions, uncertainty, and instability, which could affect the worldwide follicle-stimulating&nbsp;hormone (FSH) market. FSH product development and clinical trials would be impacted, which would slow down innovation. Market participants might look for FSH production diversification and alternate sources.&nbsp;

Furthermore, pricing and demand may be impacted by the economic impact, which includes currency fluctuations and modifications to market dynamics. There may be regional variances, with nations closer to the conflict feeling the effects more immediately. In order to navigate potential obstacles and seize possibilities in the FSH market, industry stakeholders must maintain constant observation and flexibility.

<h2>Key Developments</h2>

<ul>
	<li>On April 25, 2022, the Faces of Fertility campaign, launched by Inception Fertility (Inception) in honor of National Infertility Awareness Week, aims to highlight the variety of specialists who make up Inception&#39;s clinical network. For each patient&#39;s unique fertility journey, these specialists use cutting-edge technology, cutting-edge training, scientific knowledge, and compassionate care. With the aid of cutting-edge assisted reproductive technologies like in vitro fertilization (IVF), pregenetic implantation testing (PGT), and fertility preservation services, Inception&#39;s medical staff is at the forefront of fertility care.</li>
	<li>On February 22, 2023, Bumrungrad International Hospital launched its Fertility Centre and IVF Clinic. This comprehensive organization caters to individuals and families wishing to conceive by providing a range of reproductive care services ranging from consultations to modern assisted reproductive technologies.</li>
	<li>On June 6, 2022, Myovant Sciences has chosen Onco360 as a specialty pharmacy partner for ORGOVYX&nbsp;(relugolix), a gonadotropin-releasing hormone (GnRH) antagonist that prevents the release of luteinizing hormone (LH) and follicle-stimulating&nbsp;hormone (FSH) from the pituitary gland and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with advanced prostate cancer.</li>
</ul>

Why Purchase the Report?

<ul>
	<li>To visualize the global follicle stimulating hormone market segmentation based on type, application, end user and region and understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of Follicle stimulating hormone market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as Excel consisting of key products of all the major players.</li>
</ul>

The global follicle stimulating hormone market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

For more Pharmaceuticals related reports, <a href="https://www.datamintelligence.com/industry-verticals/pharmaceuticals">please click here</a>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Type</li>
		<li>Snippet by Application</li>
		<li>Snippet by End User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing Prevalence of Infertility&nbsp;</li>
				<li>Technological Innovations in FSH Products</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High FSH Treatment Cost will Hamper the Growth&nbsp;</li>
			</ol>
			</li>
			<li>Opportunity
			<ol>
				<li>Demand for Personalized FSH Treatments&nbsp;</li>
			</ol>
			</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&rsquo;s 5 Forces Analysis&nbsp;&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID-19</li>
			<li>Scenario During COVID-19</li>
			<li>Scenario Post COVID-19</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Attractiveness Index, By Type</li>
		</ol>
		</li>
		<li>Recombinant FSH*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Urinary FSH</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Infertility Treatment*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Assisted Reproductive Technology (ART)</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Attractiveness Index, By End User</li>
		</ol>
		</li>
		<li>Infertility Center*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Hospitals</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>The U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>The U.K.</li>
				<li>France</li>
				<li>Spain</li>
				<li>Italy</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>&nbsp;Australia</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Rest of Asia-Pacific</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User&nbsp;</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Merck Serono*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Creative BioMart&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Midas Pharma GmbH&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>GenPharm&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Trumac Healthcare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Livzon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Shanghai Techwell Biopharmaceutical Co., Ltd.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Merck Sharp &amp; Dohme Corp</li>
		<li>Lee Biosolutions,Inc</li>
		<li>BIOGENIX INC.PVT.LTD.(*LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Follicle Stimulating Hormone Market Value, By Type, 2022, 2026 &amp; 2030 (US$ Billion)

Table 2 Global Follicle Stimulating Hormone Market Value, By Application, 2022, 2026 &amp; 2030 (US$ Billion)

Table 3 Global Follicle Stimulating Hormone Market Value, By End User, 2022, 2026 &amp; 2030 (US$ Billion)

Table 4 Global Follicle Stimulating Hormone Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Billion)

Table 5 Global Follicle Stimulating Hormone Market Value, By Type, 2022, 2026 &amp; 2030 (US$ Billion)

Table 6 Global Follicle Stimulating Hormone Market Value, By Type, 2021-2030 (US$ Billion)

Table 7 Global Follicle Stimulating Hormone Market Value, By Application, 2022, 2026 &amp; 2030 (US$ Billion)

Table 8 Global Follicle Stimulating Hormone Market Value, By Application, 2021-2030 (US$ Billion)

Table 9 Global Follicle Stimulating Hormone Market Value, By End User, 2022, 2026 &amp; 2030 (US$ Billion)

Table 10 Global Follicle Stimulating Hormone Market Value, By End User, 2021-2030 (US$ Billion)

Table 11 Global Follicle Stimulating Hormone Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Billion)

Table 12 Global Follicle Stimulating Hormone Market Value, By Region, 2021-2030 (US$ Billion)

Table 13 North America Follicle Stimulating Hormone Market Value, By Type, 2021-2030 (US$ Billion)

Table 14 North America Follicle Stimulating Hormone Market Value, By Application, 2021-2030 (US$ Billion)

Table 15 North America Follicle Stimulating Hormone Market Value, By End User, 2021-2030 (US$ Billion)

Table 16 North America Follicle Stimulating Hormone Market Value, By Country, 2021-2030 (US$ Billion)

Table 17 South America Follicle Stimulating Hormone Market Value, By Type, 2021-2030 (US$ Billion)

Table 18 South America Follicle Stimulating Hormone Market Value, By Application, 2021-2030 (US$ Billion)

Table 19 South America Follicle Stimulating Hormone Market Value, By End User, 2021-2030 (US$ Billion)

Table 20 South America Follicle Stimulating Hormone Market Value, By Country, 2021-2030 (US$ Billion)

Table 21 Europe Follicle Stimulating Hormone Market Value, By Type, 2021-2030 (US$ Billion)

Table 22 Europe Follicle Stimulating Hormone Market Value, By Application, 2021-2030 (US$ Billion)

Table 23 Europe Follicle Stimulating Hormone Market Value, By End User, 2021-2030 (US$ Billion)

Table 24 Europe Follicle Stimulating Hormone Market Value, By Country, 2021-2030 (US$ Billion)

Table 25 Asia-Pacific Follicle Stimulating Hormone Market Value, By Type, 2021-2030 (US$ Billion)

Table 26 Asia-Pacific Follicle Stimulating Hormone Market Value, By Application, 2021-2030 (US$ Billion)

Table 27 Asia-Pacific Follicle Stimulating Hormone Market Value, By End User, 2021-2030 (US$ Billion)

Table 28 Asia-Pacific Follicle Stimulating Hormone Market Value, By Country, 2021-2030 (US$ Billion)

Table 29 Middle East &amp; Africa Follicle Stimulating Hormone Market Value, By Type, 2021-2030 (US$ Billion)

Table 30 Middle East &amp; Africa Follicle Stimulating Hormone Market Value, By Application, 2021-2030 (US$ Billion)

Table 31 Middle East &amp; Africa Follicle Stimulating Hormone Market Value, By End User, 2021-2030 (US$ Billion)

Table 32 Merck Serono: Overview

Table 33 Merck Serono: Product Portfolio

Table 34 Merck Serono: Key Developments

Table 35 Creative BioMart: Overview

Table 36 Creative BioMart: Product Portfolio

Table 37 Creative BioMart: Key Developments

Table 38 Midas Pharma GmbH: Overview

Table 39 Midas Pharma GmbH: Product Portfolio

Table 40 Midas Pharma GmbH: Key Developments

Table 41 GenPharm: Overview

Table 42 GenPharm: Product Portfolio

Table 43 GenPharm: Key Developments

Table 44 Trumac Healthcare: Overview

Table 45 Trumac Healthcare: Product Portfolio

Table 46 Trumac Healthcare: Key Developments

Table 47 Livzon: Overview

Table 48 Livzon: Product Portfolio

Table 49 Livzon: Key Developments

Table 50 Shanghai Techwell Biopharmaceutical Co., Ltd.&nbsp; : Overview

Table 51 Shanghai Techwell Biopharmaceutical Co., Ltd.&nbsp; : Product Portfolio

Table 52 Shanghai Techwell Biopharmaceutical Co., Ltd.&nbsp; : Key Developments

Table 53 Merck Sharp &amp; Dohme Corp: Overview

Table 54 Merck Sharp &amp; Dohme Corp: Product Portfolio

Table 55 Merck Sharp &amp; Dohme Corp: Key Developments

Table 56 Lee Biosolutions,Inc: Overview

Table 57 Lee Biosolutions,Inc: Product Portfolio

Table 58 Lee Biosolutions,Inc: Key Developments

Table 59 BIOGENIX INC.PVT.LTD.: Overview

Table 60 BIOGENIX INC.PVT.LTD.: Product Portfolio

Table 61 BIOGENIX INC.PVT.LTD.: Key Developments&nbsp;

List of Figures

Figure 1 Global Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 2 Global Follicle Stimulating Hormone Market Share, By Type, 2022 &amp; 2030 (%)

Figure 3 Global Follicle Stimulating Hormone Market Share, By Application, 2022 &amp; 2030 (%)

Figure 4 Global Follicle Stimulating Hormone Market Share, By End User, 2022 &amp; 2030 (%)

Figure 5 Global Follicle Stimulating Hormone Market Share, By Region, 2022 &amp; 2030 (%)

Figure 6 Global Follicle Stimulating Hormone Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 7 Recombinant FSH Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 8 Urinary FSH Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 9 Global Follicle Stimulating Hormone Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 10 Infertility Treatment Application in Global Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 11 Assisted Reproductive Technology (ART) Application in Global Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 12 Others Application in Global Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 13 Global Follicle Stimulating Hormone Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 14 Infertility Center End User in Global Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 15 Hospitals End User in Global Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 16 Others End User in Global Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 17 Global Follicle Stimulating Hormone Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 18 North America Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 19 Asia-Pacific Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 20 Europe Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 21 South America Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 22 Middle East and Africa Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 23 North America Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 24 North America Follicle Stimulating Hormone Market Share, By Type, 2022 &amp; 2030 (%)

Figure 25 North America Follicle Stimulating Hormone Market Share, By Application, 2022 &amp; 2030 (%)

Figure 26 North America Follicle Stimulating Hormone Market Share, By End User, 2022 &amp; 2030 (%)

Figure 27 North America Follicle Stimulating Hormone Market Share, By Country, 2022 &amp; 2030 (%)

Figure 28 South America Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 29 South America Follicle Stimulating Hormone Market Share, By Type, 2022 &amp; 2030 (%)

Figure 30 South America Follicle Stimulating Hormone Market Share, By Application, 2022 &amp; 2030 (%)

Figure 31 South America Follicle Stimulating Hormone Market Share, By End User, 2022 &amp; 2030 (%)

Figure 32 South America Follicle Stimulating Hormone Market Share, By Country, 2022 &amp; 2030 (%)

Figure 33 Europe Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 34 Europe Follicle Stimulating Hormone Market Share, By Type, 2022 &amp; 2030 (%)

Figure 35 Europe Follicle Stimulating Hormone Market Share, By Application, 2022 &amp; 2030 (%)

Figure 36 Europe Follicle Stimulating Hormone Market Share, By End User, 2022 &amp; 2030 (%)

Figure 37 Europe Follicle Stimulating Hormone Market Share, By Country, 2022 &amp; 2030 (%)

Figure 38 Asia-Pacific Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 39 Asia-Pacific Follicle Stimulating Hormone Market Share, By Type, 2022 &amp; 2030 (%)

Figure 40 Asia-Pacific Follicle Stimulating Hormone Market Share, By Application, 2022 &amp; 2030 (%)

Figure 41 Asia-Pacific Follicle Stimulating Hormone Market Share, By End User, 2022 &amp; 2030 (%)

Figure 42 Asia-Pacific Follicle Stimulating Hormone Market Share, By Country, 2022 &amp; 2030 (%)

Figure 43 Middle East &amp; Africa Follicle Stimulating Hormone Market Value, 2021-2030 (US$ Billion)

Figure 44 Middle East &amp; Africa Follicle Stimulating Hormone Market Share, By Type, 2022 &amp; 2030 (%)

Figure 45 Middle East &amp; Africa Follicle Stimulating Hormone Market Share, By Application, 2022 &amp; 2030 (%)

Figure 46 Middle East &amp; Africa Follicle Stimulating Hormone Market Share, By End User, 2022 &amp; 2030 (%)

Figure 47 Merck Serono: Financials

Figure 48 Creative BioMart: Financials

Figure 49 Midas Pharma GmbH: Financials

Figure 50 GenPharm: Financials

Figure 51 Trumac Healthcare: Financials

Figure 52 Livzon: Financials

Figure 53 Shanghai Techwell Biopharmaceutical Co., Ltd.&nbsp; : Financials

Figure 54 Merck Sharp &amp; Dohme Corp: Financials

Figure 55 Lee Biosolutions,Inc: Financials

Figure 56 BIOGENIX INC.PVT.LTD.: Financials

Follicle Stimulating Hormone Market Size, Share, Industry, Forecast and outlook (2023-2030)

Oilfield Stimulation Chemical Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 12

Starting from

Muscle Stimulator Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 September 25

Starting from

Surgical Simulation Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 16

Starting from

Medical Simulation Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 September 03

Starting from

Flight Simulator Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2024 May 21

Starting from

Spinal Cord Stimulation Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 December 12

Starting from